What Is the Trading Method for Growth Stock Investing? Claire's Tempus AI Analysis | Executive Director Park Se-ik & Chesley Head of Learning & Manager Jo Jae-wan

What is the trading method for growth stock investing? Claire's Tempus AI company analysis | Executive Director Park Se-ik & Chesley Head of Learning & Manager Jo Jae-wan [Byeoljubujeon / 26.08.29.Sat]

Watch on YouTube ↗ | September 05, 2026 at 01:00 | 1:08:53 | Chesley Investment Advisory (체슬리투자자문)

Speakers

Clare Pleydell-Bouverie — Co-Head of Global Innovation, Liontrust Asset Management

Park Se-ik — CEO, ex-Chief Strategist

Im — Director

Bok — General Manager

Taeband — Analyst

Summary

The video is a weekend institutional-style stock discussion. Claire presents a detailed Tempus AI company analysis, arguing it is a precision-medicine data and platform company and suggesting gradual accumulation. Park Se-ik adds a US growth-stock entry framework around waiting for GAAP operating profit inflection, while technical and SaaS-focused panelists also express bullish Tempus AI views. Taeband presents a Bollinger Band breakout-count framework contrasting Korea's momentum behavior with US mean-reversion behavior.

Claire breaks down Tempus AI's diagnostic testing and pharma data businesses and its integrated precision-medicine OS strategy.
Key growth metrics: Q2 cancer test volume +31%, data/application revenue +28%, adjusted EBITDA positive, but GAAP operating loss and SBC remain large.
Park Se-ik uses Palantir's GAAP operating-profit inflection as a template for timing US innovative growth stocks.
Director Im discloses an initial Tempus AI long on breakout volume and sees first-wave trading opportunity.
General Manager Bok reframes Tempus AI as a medical SaaS/data platform with roughly 90% big pharma connectivity and plans to accumulate.
Taeband's Bollinger breakout-count data shows Korea is momentum-style while the US is mean-reverting, especially after a -15% drawdown.
The panel concludes current index signals are mostly cautious or quiet and require confirmation from other indicators.

Ideas

Clare Pleydell-Bouverie Head of Learning 1:08

Accumulate Tempus AI on integrated data platform.

Tempus AI is building a precision-medicine operating system, not just a diagnostics business. Its diagnostic testing creates patient touchpoints and data, and that data is de-identified and sold to pharma for drug development and clinical trial design, creating a second revenue stream. Recent M&A extends the patient relationship from early cancer risk through post-treatment MRD monitoring. Industry tailwinds include Moderna's personalized mRNA cancer therapy, SoftBank's Japan JV, and Ark Invest's large position; Google Cloud's usage-linked financing also aligns incentives. Q2 cancer test volume rose 31% and data revenue rose 28%, and adjusted EBITDA turned positive, though GAAP operating losses and SBC remain large. Claire views the growth direction positively and suggests gradual accumulation rather than chasing all at once, with GAAP operating profit inflection as the key confirmation.

Park Se-ik CEO, ex-Chief Strategist 23:40

Wait for GAAP operating profit inflection in US growth stocks.

For innovative US growth companies that can change the world, investors should not buy too early while they are deeply loss-making. Palantir is the template: after its first GAAP operating profit quarter in Q1 2023, the stock began its real repricing even though the market bottomed earlier in late 2022. If a company will not earn within three years, investors should wait. Once operating profit inflects, entering even then can still capture a 10x move. This timing framework is directly relevant to evaluating Tempus AI.

Taeband Analyst 46:31

Trade Korean momentum with Bollinger breakout counts.

Using Bollinger Band breakout counts for KOSPI 200 and KOSDAQ 150, Korea behaves as a momentum market. When upper-band breakouts exceed 30 and lower-band breakdowns exceed 50, buying and holding has historically worked because retail-driven flows chase hot themes. When both upper and lower breakout counts shrink, the market is in a quiet phase and participants are already cautious; the current quiet phase warrants monitoring and caution. The indicator is a market temperature gauge, not a prediction, and should be used with other indicators.

Taeband Analyst 47:19

Buy US indices after cold mean-reverting setups.

US equities are mean-reverting in this indicator, unlike Korea. When upper-band breakouts are numerous, US markets tend to rest or pull back. When lower-band breakdowns are numerous, and especially when the index has drawn down about 15% or more, buying S&P 500 and Nasdaq-100 has historically had about a 74% win rate. If the market does not pull back to -15%, the data suggests not buying. Daily Bollinger monitoring is less useful; VIX or index-level fear can suffice. The indicator should be used as a market temperature gauge rather than exact daily timing.

Up Next

GPT-6 Hits AGI? Tech Euphoria 2.0, SF Mansion Shortage, NYC Bans AI in Schools & Venezuela Oil Deal

All-In Podcast · Sep 04

Anxious individuals dumped 3 trillion in Samsung Electronics and SK Hynix... But now is not the time to be scared and dump stocks | Aurora Investment Advisory CEO Lee Jihwan

815 Money Talk (815머니톡) · Sep 04

Trump Demands Rate Cut After Jobs Report

Bloomberg Markets · Sep 04

Mad Money 09/04/26 | Audio Only

This industry" will explode when semiconductors falter. Which industry's stock price will reverse in October? | Yeo Doe-eun, Lee Seon-yeop AFW Partners CEO [Weekend Interview]

3PRO TV (삼프로TV) · Sep 04

This Chesley Investment Advisory (체슬리투자자문) video, published September 05, 2026, features Clare Pleydell-Bouverie, Park Se-ik, Taeband discussing TEM, IWF, KOSPI 200, KOSDAQ 150, SPY, ^NDX. 4 trade ideas extracted by AI with direction and confidence scoring.

Speakers: Clare Pleydell-Bouverie, Park Se-ik, Taeband · Tickers: TEM, IWF, KOSPI 200, KOSDAQ 150, SPY, ^NDX